Verastem Inc. (VSTM)
NASDAQ · Healthcare
Verastem Inc. Shareholder Equity 2018–2025
Verastem Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Verastem Inc. shareholder equity for the quarter ending December 31, 2025 were 57.2M, a 297.96% decrease year-over-year.
- Verastem Inc. shareholder equity for 2025 were 57.2M, a 297.96% decrease from 2024.
- Verastem Inc. shareholder equity for 2024 were -28.9M, a 160.97% decrease from 2022.
- Verastem Inc. shareholder equity for 2022 were 47.4M, a 45.88% decrease from 2021.
- Verastem Inc. shareholder equity for 2021 were 87.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Verastem Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $57 |
| 2024 | $-29 |
| 2022 | $47 |
| 2021 | $88 |
| 2020 | $115 |
| 2019 | $7 |
| 2018 | $124 |
| Verastem Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $57 |
| 2024-12-31 | $-29 |
| 2022-12-31 | $47 |
| 2021-12-31 | $88 |
| 2020-12-31 | $115 |
| 2019-12-31 | $7 |
| 2018-12-31 | $124 |
Verastem Inc. Shareholder Equity — FAQ
Verastem Inc. (VSTM) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VSTM's shareholder equity history?
The chart and table above show Verastem Inc.'s shareholder equity by year and by quarter, including the growth rate.